Table 3.
Treatment Utilization Among High-Risk Patients Admitted to Teaching Hospitals for Acute Myocardial Infarction, Heart Failure, or Cardiac Arrest During Dates of 2 National Cardiology Meetings
| Condition and Treatment Utilization |
Adjusted (95% CI) | P Value | |
|---|---|---|---|
| Meeting Dates | Nonmeeting Dates | ||
| Acute Myocardial Infarction | |||
| PCI, % | 20.8 (15.3 to 26.3) | 28.2 (25.5 to 30.8) | .02 |
| Circulatory support, %a | 20.3 (14.5 to 26.1) | 20.1 (17.3 to 22.8) | .93 |
| CABG, % | 11.3 (7.9 to 14.7) | 8.6 (7.5 to 9.8) | .12 |
| Hospital charges, $ | 92 611 (76 165 to 109 058) | 88 562 (79 945 to 97 178) | .63 |
| Length of stay, d | 9.5 (8.1 to 10.9) | 9.3 (8.8 to 9.8) | .77 |
| Heart Failure | |||
| Catheterization or monitoring, %b | 2.2 (0.8 to 3.7) | 2.7 (1.8 to 3.6) | .54 |
| CABG, % | 1.1 (−0.5 to 2.8) | 0.6 (−0.1 to 1.2) | .32 |
| Hospital charges, $ | 50 779 (42 329 to 59 228) | 55 685 (49 011 to 62 358) | .17 |
| Adjusted length of stay, d | 8.2 (7.5 to 8.9) | 8.5 (8.0 to 8.9) | .43 |
| Cardiac Arrest | |||
| PCI, % | 6.5 (2.7 to 10.4) | 5.9 (3.8 to 8.0) | .75 |
| CABG, % | 3.1 (0.4 to 5.8) | 2.3 (1.0 to 3.6) | .50 |
| Hospital charges, $ | 112 716 (84 313 to 141 119) | 86 322 (76 858 to 95 787) | .07 |
| Length of stay, d | 11.7 (9.2 to 14.3) | 9.3 (8.3 to 10.3) | .07 |
Abbreviations: CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.
a
Includes intra-aortic balloon pump counterpulsation or peripherally inserted ventricular assist device.
b
Diagnostic catheterization of the right side of the heart or invasive hemodynamic monitoring with tailored therapy.